Greyson International Inc (CE) (GYSN) Noticias

Danger!! GYSN Securities about to be Restricted..!!

Nice slaps

Getting ready for .10

250X AVG VOLUME~ WATCH FOR UPDATES FILINGS~ EASY COPPER RUN COMING~ $GYSN

ADDING HERE AS OF LATE~ SOMETHING TELLS ME THEY ARE CLOSE TO FILING AND UPDATES COMING~ EXPECTING A COPPER BREAK SOON~ MASSIVE RUN COMING IMHO~ GYSN

waiting till this smells right..

Grayson International Inc, continues to work with third-party companies who are evaluating the Trilexon delivery system for use In pharmaceutical and other industries. Greyson Is exploring strategic partners to market it’s cosmetic line.

Come-On $GYSN, we been hearing that same story for years.

Let’s see if more Q filings come in and we go current— this thing clearly moves easily on volume

Company filed financials on otcmarkets.com

Why is this up?

biggest scam pumper bs ive ever seen .. forgot stock manipulator ive ever seen.. should be banned and in jail

amen

makin top ticks arrived ...TIMBBBERRRRRR

$GYSN: $0.0092 going............. going for Pennybreaker



Look at her gooooooooooooooooooooooo



Here we gooooooooooooooooooooooooooooooooo



GO $GYSN

$GYSN: $0.008 going now......... bigggggggg breaker


There she goes.



Large volume coming in






GO $GYSN

Nice little pop today. I see a new website also.

blind here, all I do is listen..

Are you posting the right board?!? Before my first post on GYSN it’s been 2yrs since any other. Also, I don’t see anyone from AGGI except Halbroke1 & that wasn’t until after you posted. Seems you guys arguing over there, why come here to argue ?!?

GYSN $$$ COULD BE READY TO RUN HARD...IM LOADING MORE..ARE YOU BLIND, FILINGS HIT YESTERDAY...

Take a look at AGGI...the same pumpers just scammed that one. Same exact set up here

Anyone know what’s happening here as of late?

This is a dog that doesn't hunt.

Fun Fact

If Harvey Tauman had wanted to swindle Welfare like he did his shareholders, he would have needed 128 children.

Are you the reason why GYSN is up? Under normal circumstances this would be still .0025, GYSN is a dead stock. No news since September 2014, no progress, there is absolutely nothing.

GYSN is up from .0025 to .014 without news, without a sign anything will happen and with low volume, but steady accumulation.
I wonder who buys/bought here.

$GYSN 2nd Q fins just hit. They are not that impressive but who knows could run .003/.005

Scroll down to page 7 notes http://www.otcmarkets.com/financialReportViewer?symbol=GYSN&id=132879

This is probably the reason.

Need to find out if company has a plan and then accumulate .0025

Just because you got 200k shares, you don´t need to buy it up.

With patience we could accumulate millions.

Who sells GYSN at .003? Company is active on facebook, last pr September 2014, last filing May 14, 2015.

Can we expect anything positive here? Down from multi pennies with low volume.

Authorized Shares 200,000,000 a/o Dec 31, 2014
Outstanding Shares 151,093,964 a/o Dec 31, 2014

http://greysonintl.com/

https://www.facebook.com/GreysonInternationalInc?ref=hl

Rest in peace Harvey.

If you can.

Redskin.

I am still waiting for it. If there were more to say, then I wouldn't have lost my mod privileges.

March 14, 2014 ... where's the BEEF? Rayo ... I heard a pin drop ... where's the "powerful" message my brother?

Red

Greyson International Inc. (otc pink sheets:GYSN) Hires TransMedia Group To Deliver Its Powerful Trilexon Story

BOCA RATON, Fla., Feb. 10, 2014 /PRNewswire/ -- Greyson International Inc. (otc pink sheets:GYSN) has retained TransMedia Group to introduce its patented transdermal delivery system Trilexon ( www.greysonintl.com )focusing on both the beauty and pharma sectors in delivering anti-aging and prescription ingredients through the skin for maximum effectiveness.

TransMedia ( www.transmediagroup.com ) said it will publicize how Trilexon can resuscitate expiring pharmaceutical patents and save sales that otherwise would be lost over an ever widening, precipitous patent cliff. TransMedia said it also will publicize a skin care line that Greyson plans to launch in the near future. The industry stands to lose an estimated $90 billion from expired patents.

"When patents expire, companies face steep competition, causing revenues to drop off along with the value of their stock," said Greyson Legal consultant Joe Bovino, "but Trilexon is a game changer as it will extend patent life of medications and other products."

According to Greyson's President and CEO Harvey Tauman, Trilexon enables active ingredients to be delivered topically instead of through the blood stream via swallowing a pill.

"Our publicity will show Trilexon enables ingredients to last longer and have greater impact as they're contained in a unique emulsion. Once water insoluble Trilexon is applied to skin, it acts as a breathable environmental dome, sealing in moisture and balancing pH," said TransMedia CEO Tom Madden.

In his illustrious 40-year career in the cosmetics industry, Tauman was twice responsible for triple stock splits in companies he led and scoring a one-day record $2 million in sales on QVC, culminating in over $100 million in sales of his past cosmetic products, said Madden.

Greyson's Brand Manager Tia Castle said that within Trilexon's unique environment, actives such as medications, antioxidants and vitamins are able to release their full potential.

TransMedia said its publicity will show how Trilexon has the potential to reduce drug interaction and addictiveness and provide a power boost for skin and hair and long lasting SPF's.

TransMedia will highlight how Greyson VP Mukeh Prasad assisted the late Charley Fox in developing Trilexon and how Fox believed Trilexon will help everyone in a way never thought possible.

Media contact: Iviani Figueroa 561-750-9800 x233; iviani@transmediagroup.com .

SOURCE TransMedia Group

Copyright (C) 2014 PR Newswire. All rights reserved

Yeah he told me. It was a bad situation. I was disappointed on several levels as I didn't understand the problem. So I only have Greg's side on it. Someday maybe.

The call went very well. Harvey has been consistent all along. Tia is the real deal. We shall see how things go.

So how'd the call go? Dadgummit bailed ...

Greyson International Inc. to Hold Investor Conference Call on Thursday, November 21, 2013

COCONUT CREEK, Fla., Nov 19, 2013 (BUSINESS WIRE) -- Greyson International, Inc. (otc pink sheets:GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that it would be holding an investor conference call on Thursday, November 21, 2013, at 4:15 pm EST. The conference call dial in number is 530-881-1300 and the Participant Access Code is 934487. The recorded version of the conference call will be available for playback after the call is concluded. Dial 530-881-1399 to listen.

"Our company has laid the foundation and set into motion the launch of Greyson Skincare, licensing deals and pharmaceutical joint ventures. I'm looking forward to giving details on these activities," said Harvey Tauman, CEO of Greyson International Inc. "In addition, I'm looking forward to discussing our future plans on this call, as we bring our patented Trilexon trans-dermal delivery system to market and ultimately unlock significant value for our shareholders in 2014 and beyond."

In preparation you may view the new videos on the Greyson website.

GYSN at .09 I wonder if we are getting ready to hear good things?

Credit genuineoil elsewhere.......




Good and informative

https://greysonintl.com/
https://greysonintl.com/trilexon-4/
https://greysonintl.com/order-products/
https://greysonintl.com/damage-control-skin-care/

~ $GYSN ~ Daily Par Sar Buy Signal ~ Criteria alert triggered during a recent trading session!

$GYSN has just triggered the "Parabolic SAR Buy Signals" scan criteria at Stockcharts.com
~ http://tinyurl.com/SAR-BUY ~







For a more in Depth study and DD profile, similar to the one contained in this link: ~ http://tinyurl.com/DDexample ~
Click the following link and type ticker or brief message asking me about the DD: ~ http://tinyurl.com/GET-THE-DD ~

What does the scan "Parabolic SAR Buy Signals" mean? Below is an image example and study link.
~ http://stockcharts.com/school/doku.php?id=chart_school:technical_indicators:parabolic_sar ~


To find other similar posts of "GYSN" utilize the links that follow.
Search MACDgyver's "Parabolic SAR Buy Signals" posts: ~ http://investorshub.advfn.com/boards/msgsearchbymember.aspx?searchID=251916&srchyr=2013&SearchStr=ParSarBuyScan ~
Search MACDgyver's posts for symbol "GYSN": ~ http://investorshub.advfn.com/boards/msgsearchbymember.aspx?searchID=251916&srchyr=2013&SearchStr=GYSN ~
Search Ihub for "GYSN" posts: ~ http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=GYSN ~


For more in depth training and information visit Chartschool on the Stockcharts page.
~ http://stockcharts.com/school/doku.php?id=chart_school ~


Also don't forget the Ihub Edu Channel.
~ http://investorshub.advfn.com/boards/education.aspx ~


c

http://finance.yahoo.com/news/greyson-international-inc-receives-industry-152700258.html



Related Content

RELATED QUOTES
Symbol Price Change
GYSN 0.085 +0.0135

COCONUT CREEK, Fla.--(BUSINESS WIRE)--

Greyson International Inc. (OTC Pink Sheets: GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that talks with patent law firm Lerner Greenberg Stemer LLP resulted in across the board agreement with Greyson’s plan to help save and stave the potential $90+ billion loss in the pharmaceutical market.

Large pharmaceutical companies are facing a so-called “patent cliff”, whereby brand names drugs, once having delivered steady sales and profits are losing, or have already lost, their patent protection. Johnson and Johnson (JNJ) has had three blockbuster drug patents expire in the last two years, Eli Lilly’s (LLY) Cymbalta loses its patent at the end of 2013, and Pfizer (PFE) recently attained a short extension on multibillion-dollar Celebrex which expires in Dec. 2015.

Lerner Greenberg Stemer LLP patent law firm for the world’s largest multinational corporations concur with Greyson’s plan to utilize their patented Trilexon® trans-dermal topical delivery system in several ways. “Leveraging our technology, large pharmaceutical companies can potentially reformulate their drugs to be delivered topically instead of orally, extend patent lives, and/or create new patents quickly under the Greyson umbrella” said Harvey Tauman, CEO of Greyson International Inc. “Greyson International, in addition to being debt free, has invested millions over a period of about 20 years culminating to the point whereby preparation is meeting opportunity.”

Currently Greyson International has anchored a large manufacturer, added two prominent physicians as consultants, and recruited top industry beauty consultants for Greyson Skincare® with Trilexon® technology. Their new spokesperson and brand manager, Tia Castle is preparing to launch Greyson Skincare line on network shopping television toward the fourth quarter of 2013. Greyson is open to adding new talent to the managerial team as it rapidly expands to meet market demands. All inquiries may contact Harvey Tauman.

Greyson International’s revolutionary patented Trilexon® delivery system allows the finest ingredients to be released topically over an extended period of time, while maintaining the skin’s natural intracellular barrier to promote natural moisture and lipid levels, providing a comfortable and durable experience that’s unlike anything else in the market.



Contact:
Greyson International Inc.
Harvey Tauman, 954-482-0497, Harvey@greysonintl.com
Chief Executive Officer

I am pretty sure that is why he did the sale of Blake Oil assets. So he wouldn't have to dilute his ownership.

Tia Castle



Not just a pretty lady.

press release

July 2, 2013, 3:20 p.m. EDT
Greyson International Inc. Builds Talent Pool in Preparation for Resolving Patent Cliff Panic

COCONUT CREEK, Fla., Jul 02, 2013 (BUSINESS WIRE) -- Greyson International Inc. (otc pink sheets:GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that it recruited Tia Castle for the position of Brand Manager and Beauty Spokes Person for Greyson Skincare with Trilexon(R) technology.

"Tia brings more than 15 years' experience in both pharmaceutical sales and marketing with drug giant Johnson & Johnson (J&J). She is also an established on-air TV and film personality," said Harvey Tauman, CEO of Greyson Inc. Ms. Castle's immediate role will be to manage the launch of Greyson Skincare on shopping networks, targeted for later this year, and appear as the on-air spokesperson. "I am excited to come on board full time, as I believe in Greyson's ability to become a worldwide leader in skincare and pharmaceuticals. The potential to help companies stave off and recover from the 'patent cliff' is an enormous opportunity that needs immediate implementation," said Tia Castle.

The "patent cliff" is a big pharma company problem whereby brand name drugs that have delivered steady sales and profits are losing their patent protection. Greyson's next news release will be detailing how their Trilexon(R) delivery system will give hope to the industry regarding the potential $90 billion loss.

Greyson International's revolutionary patented Trilexon(R) delivery system allows the finest ingredients to be released topically over an extended period of time, while maintaining the skin's natural intracellular barrier to promote natural moisture and lipid levels, providing a comfortable and durable experience that's unlike anything else in the market.

Somehow I think Harvey has all he will ever need already. At least they can still trade huh!

Really Rayo?

Harvey is lining his pockets .... he's doing research on if he likes the Mango Chicken or Filet Mignon with mushroom sauce.

Give me a break ... his other oil buddies are benefitting too no less.

press release

June 10, 2013, 12:04 p.m. EDT
Greyson International Provides an Update on its Operations

COCONUT CREEK, Fla., Jun 10, 2013 (BUSINESS WIRE) -- Greyson International Inc. (otc pink:GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced the sale of a portion of its interest in Blake Oil & Gas Limited ("Blake"), a privately owned, Guernsey registered oil and Gas Company with operations in the country of Georgia. The proceeds of approximately $1 million will be used to aggressively pursue retail distribution deals for its breakthrough Trilexon(R) powered products, as well as market Greyson Bio medical's technology to potential licensees in the pharmaceutical industry.

Covered by U.S. Patent 8,268,335, Greyson International's Trilexon(R) technology combines a cationic emulsifying agent, oil soluble liquid polymer and natural occurring lactate buffer system to dramatically improve the topical delivery of active ingredients in both the cosmetics and pharmaceutical industries.

"The sale of a portion of our interest in Blake provides us with the funding necessary to unlock the enormous potential in our breakthrough Trilexon(R) delivery technology across multiple end markets," said Greyson International Inc. CEO Harvey Tauman. "We believe that Trilexon(R) will play a vital role in both the hypercompetitive cosmetics industry, where companies are always looking for a competitive edge, and the pharmaceutical industry where the larger players are facing so-called patent cliffs, and are looking for new ways to extend patent lives."

Management will provide additional details about these programs as they are implemented over the coming months.

About Greyson International, Inc.

Greyson's primary focus is on its recently patented Trilexon(R) delivery system. In addition to cosmetic applications, Trilexon(R) may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon(R) is a registered trademark of Greyson International Inc. For more information, visit our website; http://greysonintl.com and join the Greyson International's Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management's view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

http://cts.businesswire.com/ct/CT?id=bwnews&sty=20130610006165r1&sid=cmtx6&distro=nx

SOURCE: Greyson International Inc.

Yeah, I sure would like to see something substantive.

??????? 17,400 ??????????

Looks like another DUMP coming ... back to .05 ??? NO support here. No REAL news.

Descent volume move up lately. What is going on?